{"id":50809,"name":"VAXXINITY, INC.","slug":"vaxxinity-inc","state":"TX","country":"United States of America","description":"Biotechnology company","totalSpending":190000,"filings":6,"yearlySpending":[{"year":2022,"income":190000}],"issues":[{"code":"AER","display":"Aerospace"},{"code":"DEF","display":"Defense"},{"code":"MAN","display":"Manufacturing"},{"code":"HCR","display":"Health Issues"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"VET","display":"Veterans"}],"firms":["BUCHANAN INGERSOLL & ROONEY PC"],"lobbyists":["ELIZABETH WESTBROOK","MICHAEL STRAZZELLA","TIMOTHY COSTA","EMILY COYLE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Natl Institutes of Health (NIH)","Natl Aeronautics & Space Administration (NASA)","Defense, Dept of (DOD)","Commerce, Dept of (DOC)","Veterans Affairs, Dept of (VA)"],"sampleDescriptions":["Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.","Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.","Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.","Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease.","Strategy development and implementation of federal government relations initiatives relating to research and development of space and defense medicine; and chronic neurological and heart disease."]}